| Name | Affiliation | Information |
|---|
Amy Hughes Lansing, PhD | Dr. Hughes Lansing's primary research interest is in examining how biological, behavioral, and social systems interact in explaining health behaviors in youths and families and translating that knowledge into highly accessible interventions. Her current projects focus on improving health outcomes in youths with type 1 diabetes and in families with a child with congenital heart disease as well as prevention of problematic substance use in emerging adults with chronic pain. | Email | PubMed | CV |
 Sherrie Khadanga, MD | Dr. Khadanga's research program has focused on behavioral change among cardiac patients. This has included ways to improve utilization of cardiac rehabilitation (CR) and also to optimize the exercise training response for women in cardiac rehabilitation. Currently, she is examining the role of case management for improving secondary prevention of coronary artery disease and adherence among women. | Email | PubMed | CV |
Eli Klemperer, PhD | Dr. Klemperer's research primarily focuses on policy and clinical interventions to address tobacco use with a particular focus on adults who express little or no motivation to quit smoking. His current research includes an ongoing trial to examine two nicotine reduction approaches among people who use tobacco and are not ready to quit as well as a national randomized controlled trial of smoking cessation treatment for young adults who use both cigarettes and e-cigarettes. | Email | PubMed | CV |
.tmb-thumb160.jpeg?sfvrsn=bd3bebd2_1 "Peck_Kelly_Resize") Kelly Peck, PhD
| Dr. Peck's primary research and clinical interests are two-fold. First, he has conducted research focused on the development and evaluation of novel treatments for opioid use disorder (OUD). Most recently, this has included randomized clinical trials evaluating a novel interim buprenorphine treatment for reducing illicit opioid use and other high-risk behaviors among adults with untreated OUD. Second, he has worked extensively to address co-occurring PTSD in individuals with substance use disorders (SUDs), particularly around the delivery and evaluation of cognitive-behavioral treatments for PTSD. | Email | PubMed | CV |
 Eric Thrailkill, PhD | Dr. Thrailkill is focused on 1) the relationship between loss aversion, or the tendency for potential losses to have a stronger influence on behavior than equivalent gains, and risk for cigarette smoking and other substance use, 2) understanding the sequential, "chained" structure of instrumental behavior and how this informs how we make and break habits whether healthy or not, and 3) variables that influence the effectiveness of treatments that involve differential reinforcement. I collect data with in-person samples, including drug self-administration, and remote crowdsourced samples. | Email | PubMed | CV |